Staring down from the bench at the former CEO of KV Pharmaceutical, a federal judge portrayed Marc Hermelin as an example of capitalism gone awry. Hermelin pleaded guilty to two criminal misdemeanor charges of mislabeling drugs. Report
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Comments